Screener
Abbott ABT Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Diagnostic Products | $3.09B+42.3% | $2.18B+6.1% | $2.46B-2.5% | $2.25B-6.6% | $2.17B-1.0% | |
| Established Pharmaceuticals | $1.5B+8.4% | $1.43B+13.2% | $1.38B+9.0% | $1.51B+7.5% | $1.38B+6.9% | |
| Medical Devices | $5.85B+9.0% | $5.54B+13.2% | $5.68B+12.3% | $5.45B+14.8% | $5.37B+13.4% | |
| Nutritional Products | $2.14B-3.1% | $2.02B-6.0% | $1.94B-8.9% | $2.15B+4.2% | $2.21B+2.9% | |
| Net Sales by Geography | ||||||
| International | $7.38B+7.4% | $6.89B+11.3% | $7.08B+6.7% | $7.07B+9.9% | $6.87B+6.6% | |
| United States | $5.22B+22.0% | $4.27B+2.5% | $4.38B+1.0% | $4.3B+2.3% | $4.28B+8.7% |
FAQ
- How does Abbott break its business down?
- Abbott (ABT) reports net sales by business across 4 parts — Diagnostic Products, Established Pharmaceuticals, Medical Devices and Nutritional Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Abbott's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Abbott's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
